Appras Tablet 5 mg contains Prasugrel Hydrochloride 5 mg, an antiplatelet medication used to prevent blood clots in patients at risk of cardiovascular events. It is primarily prescribed for adults undergoing percutaneous coronary intervention (PCI), such as angioplasty or stent placement, to reduce the risk of heart attack, stroke, or stent thrombosis.

Prasugrel works by inhibiting platelet aggregation, preventing platelets from clumping together and forming harmful clots within blood vessels. By targeting platelet activity, Appras 5 mg helps maintain blood flow in coronary arteries and supports cardiovascular health in patients with coronary artery disease.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Prasugrel Hydrochloride 5 mg

Mechanism of Action

Prasugrel is a thienopyridine class antiplatelet agent. Its action involves:

• Irreversibly inhibiting the P2Y12 ADP receptor on platelets

• Preventing ADP-mediated platelet activation and aggregation

• Reducing the risk of arterial thrombus formation in high-risk cardiovascular patients

By directly targeting platelet function, Prasugrel effectively prevents clot-related complications such as myocardial infarction and stroke without affecting the coagulation cascade.

Indications

Appras Tablet 5 mg is indicated for:

• Prevention of thrombotic cardiovascular events in adults undergoing PCI

• Reduction of heart attack risk in patients with acute coronary syndrome (ACS)

• Prevention of stent thrombosis following coronary stent placement

• Patients at high risk of arterial blood clots, as determined by a cardiologist

Benefits

• Reduces Cardiovascular Risk: Prevents heart attacks, strokes, and stent-related complications

• Rapid Onset of Action: Provides effective platelet inhibition shortly after administration

• Long-Term Protection: Supports ongoing cardiovascular health in high-risk patients

• Oral Administration: Convenient once-daily tablet improves adherence

• Clinically Proven: Demonstrated efficacy in reducing thrombotic events in PCI patients

Dosage and Administration

• The usual dose is 5 mg once daily, as prescribed by a healthcare professional

• Tablets should be swallowed whole with water, with or without food

• Often initiated with a loading dose in patients undergoing PCI, followed by maintenance therapy

• Do not stop therapy without medical advice, as abrupt discontinuation can increase the risk of clot formation

• Dosage adjustments may be necessary for elderly patients, low body weight (<60 kg), or those with increased bleeding risk

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

• Common side effects include bleeding, bruising, nausea, or headache

• Serious risks involve major bleeding events, such as gastrointestinal or intracranial hemorrhage

• Avoid use in patients with active bleeding, history of stroke or transient ischemic attack (TIA), or hypersensitivity to Prasugrel

• Use caution in elderly patients, those with low body weight, or concurrent use of anticoagulants

• Patients should report any unusual bleeding, nosebleeds, or black stools immediately

• Inform your healthcare provider about all other medications and medical conditions before starting therapy